[Prospects for design of novel antituberculosis drugs].
Nikitin
A V
AV
D000818:Animals; D000995:Antitubercular Agents / Q000494:pharmacology / Q000627:therapeutic use; D002473:Cell Wall / Q000187:drug effects / Q000378:metabolism; D015195:Drug Design; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D009593:Nitroimidazoles / Q000378:metabolism; D009696:Nucleic Acids / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D009593:Nitroimidazoles; D009696:Nucleic Acids; D011500:Protein Synthesis Inhibitors; D011804:Quinolines